Filing Details
- Accession Number:
- 0001708138-20-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-16 16:04:27
- Reporting Period:
- 2020-04-14
- Accepted Time:
- 2020-04-16 16:04:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238303 | J Joseph Larosa | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp General Counsel And Secret | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-14 | 5,000 | $59.20 | 19,438 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-14 | 2,738 | $521.45 | 16,700 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-04-15 | 92 | $514.63 | 16,608 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 414 | $515.70 | 16,194 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 260 | $516.81 | 15,934 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 266 | $517.40 | 15,668 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 499 | $518.25 | 15,169 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 286 | $519.43 | 14,883 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 220 | $520.45 | 14,663 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 113 | $521.05 | 14,550 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 106 | $524.99 | 14,444 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 6 | $525.30 | 14,438 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-04-14 | 5,000 | $0.00 | 5,000 | $59.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 34,933 | 2021-09-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 287 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 414 shares of Company stock on April 15, 2020 at prices ranging from $515.30 to $515.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
- Represents volume-weighted average price of sales of 260 shares of Company stock on April 15, 2020 at prices ranging from $516.06 to $516.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
- Represents volume-weighted average price of sales of 266 shares of Company stock on April 15, 2020 at prices ranging from $517.00 to $517.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
- Represents volume-weighted average price of sales of 499 shares of Company stock on April 15, 2020 at prices ranging from $518.03 to $518.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
- Represents volume-weighted average price of sales of 286 shares of Company stock on April 15, 2020 at prices ranging from $519.25 to $519.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
- Represents volume-weighted average price of sales of 220 shares of Company stock on April 15, 2020 at prices ranging from $520.29 to $520.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
